SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study

Objective: There is emerging evidence that the pancreas may be a target organ of SARS-CoV-2 infection. This aim of this study was to investigate the outcome of patients with acute pancreatitis (AP) and coexistent SARS-CoV-2 infection. Design: A prospective international multicentre cohort study including consecutive patients admitted with AP during the current pandemic was undertaken. Primary outcome measure was severity of AP. Secondary outcome measures were aetiology of AP, intensive care unit (ICU) admission, length of hospital stay, local complications, acute respiratory distress syndrome (ARDS), persistent organ failure and 30-day mortality. Multilevel logistic regression was used to compare the two groups. Results: 1777 patients with AP were included during the study period from 1 March to 23 July 2020. 149 patients (8.3%) had concomitant SARS-CoV-2 infection. Overall, SARS-CoV-2-positive patients were older male patients and more likely to develop severe AP and ARDS (p<0.001). Unadjusted analysis showed that SARS-CoV-2-positive patients with AP were more likely to require ICU admission (OR 5.21, p<0.001), local complications (OR 2.91, p<0.001), persistent organ failure (OR 7.32, p<0.001), prolonged hospital stay (OR 1.89, p<0.001) and a higher 30-day mortality (OR 6.56, p<0.001). Adjusted analysis showed length of stay (OR 1.32, p<0.001), persistent organ failure (OR 2.77, p<0.003) and 30-day mortality (OR 2.41, p<0.04) were significantly higher in SARS-CoV-2 co-infection. Conclusion: Patients with AP and coexistent SARS-CoV-2 infection are at increased risk of severe AP, worse clinical outcomes, prolonged length of hospital stay and high 30-day mortality

New Mediterranean Biodiversity Records (April, 2019)

The Collective Article on “New Mediterranean Biodiversity Records” offers the means to publish biodiversity records in the Mediterranean Sea. The current article presents new biodiversity data information on 18 taxa (14 alien, 3 native and 1 cryptogenic species) belonging to 5 Phyla that are reported for 11 different countries listed according to their geographic position from the western to the eastern Mediterranean Sea. Algeria: the alien green alga Caulerpa taxifolia var. distichophylla and the heterobranchs Aplysia dactylomeda and Aplysia punctata are first reported from the entire country. France: a new record of the alien hydroid Porpita porpita is reported from the Corsican Sea, representing the second record of the species in the western Mediterranean Sea. Tunisia: the alien fish Scatophagus argus is reported from the Gulf of Gabès, probably representing an aquarium release. Italy: the well-established Mediterranean alien bivalve Malleus regula is first reported from the entire country. Slovenia: the alien marine bivalve Xenostrobus securis is reported for the first time from the entire country. Croatia: the alien gastropod Biuve fulvipunctata is reported for the first time from the country but also from the entire Adriatic Sea. Montenegro: the alien bivalve Rapana venosa is reported for the first time from the Montenegrin waters. Albania: the well-established alien fish Lagocephalus sceleratus and the rare native shark Rhizoprionodon acutus are reported for the first from the entire country. Greece: the rare native ray Leucoraja circularis is reported for the first time from the Argolikos Gulf and for the first time for the entire country its identification is confirmed morphologically and molecularly; additional records of the alien nomad jellyfish Rhopilema nomadic document its expanding distribution, while the occurrence and the alien fishes Sillago suezensis and Pomadasys stridens are reported for the first time from Hellenic waters. Turkey: additional records of the Egyptian Prawn Metapenaeopsis aegyptia are reported with some biological information. Cyprus: the alien fish Variola louti is reported for the first time for the entire Mediterranean Sea, probably released from an aquarium, while the alien moon crab Matuta victor is reported for the first time from the entire country

Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.

To assess the efficacy and the tolerance of a split course hypofractionated (SCH) radiotherapy (RT) protocol in head and neck cancer (HNC) for eldery and/or unfit patients (pts). Pts with HNC treated by SCH-RT in two institutions were included retrospectively. The main SCH RT regimen was two courses of 30 grays (Gy)/10 fractions separated by 2-4 weeks, without any systemic therapy. Between February 2012 and January 2019, 75 consecutive patients were analyzed. The median age was 80 years (range: 45.7-98.2) and 53 (70.7%) were men. Sixty-one (81.3%) pts had stage III/IV disease and 54 (72%) had at least two comorbidities. All of them were treated with intensity-modulated radiotherapy. Median follow-up was 10.6 months (range: 3.1-58.3). Local control at 12 and 24 months was 72.8% IC95%[62-85.5] and 51.7% IC95%[38.1-70.1] respectively. Progression free survival (PFS) at 12 and 24 months were 47.7% IC95%[37.4-60.8] and 41% IC95%[15-36.4] respectively, with a median of 11.5 months IC95%[8.9-17]. OS at 12 and 24 months were 60.4% IC95%[50-73.1] and 41% IC95%[30.6-54.9] respectively, with a median of 19.3 months IC95%[11.9-25.8]. Acute and late grade 3 or higher toxicities occurred for 6 (8%) and 3 (4%) pts. The present SCH-RT regimen seems effective, well-tolerated and could represent an alternative to palliative strategies for pts deemed unfit for standard exclusive RT